Correlation Between Bionoid Pharma and HLS Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bionoid Pharma and HLS Therapeutics, you can compare the effects of market volatilities on Bionoid Pharma and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and HLS Therapeutics.

Diversification Opportunities for Bionoid Pharma and HLS Therapeutics

0.27

Correlation Coefficient

Bionoid Pharma  HLS Therapeutics

Modest diversification

The 3 months correlation between Bionoid and HLS is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Bionoid Pharma and HLS Therapeutics

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 5.54 times more return on investment than HLS Therapeutics. However, Bionoid Pharma is 5.54 times more volatile than HLS Therapeutics. It trades about 0.08 of its potential returns per unit of risk. HLS Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  59.00  in Bionoid Pharma on September 13, 2024 and sell it today you would lose (32.00) from holding Bionoid Pharma or give up 54.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.6%
Values	Daily Returns

Bionoid Pharma  vs.  HLS Therapeutics

Bionoid Pharma

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Bionoid Pharma and HLS Therapeutics

The main advantage of trading using opposite Bionoid Pharma and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.

The idea behind Bionoid Pharma and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.